ST6GAL1 and cancer: Our analysis provides evidence that the ST6GAL1 soluble form is transferred via sEVs to cancer cells and that the neighboring cancer cells may be the active recipient cells; however, it cannot be excluded that the sEVs themselves or cells (fibroblasts and immune cells) in the TME may utilize ST6GAL1.